Skip to content
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
Quest Diabetes
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
  • News & Research

Taiwan-backed project lifts diabetes care by 125% in Eswatini regions

A joint programme in Hhohho and Manzini has expanded diabetes and hypertension services, while raising questions about the resources needed to take chronic disease care nationwide. Hypertension services have risen sharply in parts of Eswatini, while diabetes care has expanded…

  • apxadmin
  • October 16, 2026
  • Patient Narratives

Why cataract surgery needs extra planning when you have diabetes

Cataract surgery is usually safe for people with diabetes, but retinal disease, macular swelling and slower healing can make assessment and follow-up more complex. For people with diabetes, cataract surgery is generally safe and often restores useful vision, but the…

  • apxadmin
  • October 16, 2026
  • Patient Narratives

Maryland man sues Novo Nordisk after blaming Ozempic for permanent blindness

Todd Engel says he lost sight in both eyes after taking Ozempic, as lawsuits allege patients were not adequately warned about a possible link to a rare optic-nerve condition. Todd Engel, a Maryland resident who says Ozempic left him permanently…

  • apxadmin
  • October 16, 2026
  • News & Research

Kailera completes ribupatide trial recruitment, setting up 2028 test against Wegovy

Kailera has enrolled about 4,900 participants in its Phase 3 KaiNETIC programme, including a direct comparison of ribupatide with semaglutide, with results now expected in mid-2028. Kailera Therapeutics has finished enrolling participants in its KaiNETIC late-stage programme, pushing results on…

  • apxadmin
  • October 16, 2026
  • Diet & Nutrition

Sequel wins FDA clearance to bring automated insulin dosing to type 2 diabetes

The clearance extends Sequel’s twiist system beyond type 1 diabetes after a trial found improved blood glucose control among adults using insulin-treated type 2 diabetes. Sequel Med Tech said its twiist automated insulin delivery system has been cleared by the…

  • apxadmin
  • October 16, 2026
  • Diet & Nutrition

Spain urges a new front line against type 1 diabetes: testing before symptoms

Spain’s leading diabetes societies have proposed a structured pathway to identify autoimmune type 1 diabetes before symptoms emerge, aiming to reduce dangerous ketoacidosis and give families earlier support. Spain’s leading diabetes groups are urging a shift towards earlier detection of…

  • apxadmin
  • October 16, 2026
  • Patient Narratives

Smart insulin system gives Warangal teenager more freedom from type 1 diabetes routine

A hybrid closed-loop pump and glucose sensor have helped a 14-year-old boy manage his diabetes with fewer manual adjustments and greater confidence at school and during activities. A 14-year-old boy from Warangal has been able to manage his type 1…

  • apxadmin
  • October 16, 2026
  • News & Research

Hua An Medical seeks fresh capital as late-stage trials and AI licensing drive expansion

Hua An Medical is raising NT$300m to advance its drug pipeline while expanding Yuanhua Smart Medicine’s AI-led repurposing and licensing business. 华安醫學 on Friday outlined an expanded push into drug development and artificial intelligence, saying it is building its business…

  • apxadmin
  • October 16, 2026
  • Lifestyle & Wellbeing

Keto diet eases stress on insulin-making cells in small diabetes trial

A 12-week University of Alabama at Birmingham trial found a ketogenic diet reduced a marker of strain in insulin-producing beta cells more than a low-fat plan, although longer studies are needed. A small trial from the University of Alabama at…

  • apxadmin
  • October 16, 2026
  • Lifestyle & Wellbeing

Seven in 10 newborns of women with diabetes faced early complications in Ugandan study

A prospective cohort study at three Ugandan referral hospitals found that 70.3% of newborns born to women with diabetes experienced at least one early adverse outcome, most commonly macrosomia. A prospective cohort study in Uganda has found that babies born…

  • apxadmin
  • October 16, 2026
Prev
1 … 19 20 21 22 23 24 25 … 199
Next

Search

No results

Posts

Link between early-onset type 2 diabetes and neurodevelopmental conditions explored at EASD

September 28, 2026

New guidelines help GLP-1 users safely observe fasting during religious holidays

September 30, 2026

Small daily walks could significantly improve blood sugar control and mental health

October 1, 2026

UK becomes first in Europe to approve oral GLP-1 weight-loss medication for adults with obesity and type 2 diabetes

August 10, 2026

Egyptian MPs demand transparency on local insulin quality amid health security concerns

August 16, 2026

Trending now

Lipid risk marker flags hidden kidney and nerve damage risk in type 2 diabetes
New guidelines help people with diabetes enjoy summer cookouts without guilt
Gestational diabetes alters early brain response to food cues during pregnancy
Personal glucose pattern analyser offers targeted insights for diabetes management

Copyright © 2026 - QuestDiabetes.com

Disclaimer | Terms & Conditions | Privacy Policy